Tempest Therapeutics
Recent News About Tempest Therapeutics
-
42 San Mateo-area biopharma companies could be negatively impacted by Inflation Reduction Act drug provision
A provision of the “Inflation Reduction Act” (IRA) could threaten investments in "small molecule" drug development, said the head of the Pasadena-based Pacific Research Institute (PRI).